Tumor-derived Mutations in the TRAIL Receptor DR5 Inhibit TRAIL Signaling through the DR4 Receptor by Competing for Ligand Binding.

APA

Lianghua Bin, Thorburn, J., Thomas, L. R., Clark, P. E., Humphreys, R., & Thorburn, A. (2007). Tumor-derived Mutations in the TRAIL Receptor DR5 Inhibit TRAIL Signaling through the DR4 Receptor by Competing for Ligand Binding. Journal of Biological Chemistry, 282(38), 28189–28194. https://doi.org/10.1074/jbc.M704210200

CHICAGO

Lianghua Bin, Jacqueline Thorburn, Lance R. Thomas, Peter E. Clark, Robin Humphreys, and Andrew Thorburn. 2007. “Tumor-Derived Mutations in the TRAIL Receptor DR5 Inhibit TRAIL Signaling through the DR4 Receptor by Competing for Ligand Binding.” Journal of Biological Chemistry 282 (38): 28189–94. doi:10.1074/jbc.M704210200.

HARVARD

Lianghua Bin et al. (2007) ‘Tumor-derived Mutations in the TRAIL Receptor DR5 Inhibit TRAIL Signaling through the DR4 Receptor by Competing for Ligand Binding’, Journal of Biological Chemistry, 282(38), pp. 28189–28194. doi:10.1074/jbc.M704210200.

MLA

Lianghua Bin, et al. “Tumor-Derived Mutations in the TRAIL Receptor DR5 Inhibit TRAIL Signaling through the DR4 Receptor by Competing for Ligand Binding.” Journal of Biological Chemistry, vol. 282, no. 38, Sept. 2007, pp. 28189–94., https://doi.org/10.1074/jbc.M704210200.

TURABIAN

Lianghua Bin, Jacqueline Thorburn, Lance R. Thomas, Peter E. Clark, Robin Humphreys, and Andrew Thorburn. “Tumor-Derived Mutations in the TRAIL Receptor DR5 Inhibit TRAIL Signaling through the DR4 Receptor by Competing for Ligand Binding.” Journal of Biological Chemistry 282, no. 38 (September 21, 2007): 28189–94. doi:10.1074/jbc.M704210200.